Biography and Research Information
OverviewAI-generated summary
Roaa Hadi's research focuses on advancements in CRISPR-based technologies for diagnosing and treating COVID-19. Her work explores the application of these gene-editing tools in developing novel therapeutic strategies and improving diagnostic accuracy for the virus. Hadi has published one paper on this topic, which has garnered 9 citations. She has collaborated with Shilpi Agrawal, Shivakumar Sonnaila, and Venkata Suryanarayana Murthy Bhavaraju, all from the University of Arkansas at Fayetteville, on shared publications.
Metrics
- h-index: 1
- Publications: 2
- Citations: 12
Selected Publications
-
The Role of Biomaterials in Enhancing Cell Therapy (2026)
-
Optimizing automated layer-by-layer deposition of engineered ECM-like microenvironments for mammalian cell culture (2025)
-
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics (2024)
Collaboration Network
Top Collaborators
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
Similar Researchers
Based on overlapping research topics